Edwards Lifesciences Corp Stock Performance
| EW Stock | USD 77.57 4.53 5.52% |
The firm shows a Beta (market volatility) of -0.11, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Edwards Lifesciences are expected to decrease at a much lower rate. During the bear market, Edwards Lifesciences is likely to outperform the market. At this point, Edwards Lifesciences Corp has a negative expected return of -0.0187%. Please make sure to confirm Edwards Lifesciences' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Edwards Lifesciences Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Edwards Lifesciences Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Edwards Lifesciences is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Actual Historical Performance (%)
One Day Return (2.84) | Five Day Return (2.24) | Year To Date Return (6.52) | Ten Year Return 186.26 | All Time Return 5.7 K |
Last Split Factor 3:1 | Last Split Date 2020-06-01 |
1 | Disposition of 583 shares by Markowitz Wayne of Edwards Lifesciences at 86.01 subject to Rule 16b-3 | 12/08/2025 |
2 | Disposition of 2615 shares by Heisz Stone of Edwards Lifesciences at 83.4109 subject to Rule 16b-3 | 12/12/2025 |
3 | Edwards Lifesciences Reassessing Valuation After Strong Sales Growth and Upgraded Guidance | 12/17/2025 |
4 | Disposition of 330 shares by Daniel Lippis of Edwards Lifesciences at 45.2767 subject to Rule 16b-3 | 01/02/2026 |
5 | Disposition of 8708 shares by Donald Bobo of Edwards Lifesciences at 85.9793 subject to Rule 16b-3 | 01/06/2026 |
6 | Court sides with FTC to block Edwards Lifesciences JenaValve acquisition | 01/09/2026 |
7 | IBD Rating Upgrades Edwards Lifesciences Flashes Improved Technical Strength | 01/16/2026 |
8 | Edwards Lifesciences Valuation Check After Mixed Share Price Momentum And Premium PE | 01/21/2026 |
9 | Acquisition by Kieran Gallahue of 3528 shares of Edwards Lifesciences subject to Rule 16b-3 | 01/27/2026 |
10 | J. Safra Sarasin Holding AG Buys New Shares in Edwards Lifesciences Corporation EW - MarketBeat | 01/29/2026 |
11 | Meet Skyler Rivera, s new associate editor | 01/30/2026 |
12 | Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference | 02/02/2026 |
| Begin Period Cash Flow | 1.1 B | |
| Total Cashflows From Investing Activities | 2.3 B |
Edwards Lifesciences Relative Risk vs. Return Landscape
If you would invest 8,339 in Edwards Lifesciences Corp on November 7, 2025 and sell it today you would lose (129.00) from holding Edwards Lifesciences Corp or give up 1.55% of portfolio value over 90 days. Edwards Lifesciences Corp is generating negative expected returns and assumes 1.2167% volatility on return distribution over the 90 days horizon. Put differently, 10% of stocks are less risky than Edwards on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Edwards Lifesciences Target Price Odds to finish over Current Price
The tendency of Edwards Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 77.57 | 90 days | 77.57 | close to 99 |
Based on a normal probability distribution, the odds of Edwards Lifesciences to move above the current price in 90 days from now is close to 99 (This Edwards Lifesciences Corp probability density function shows the probability of Edwards Stock to fall within a particular range of prices over 90 days) .
Edwards Lifesciences Price Density |
| Price |
Predictive Modules for Edwards Lifesciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Edwards Lifesciences Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edwards Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edwards Lifesciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Edwards Lifesciences is not an exception. The market had few large corrections towards the Edwards Lifesciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Edwards Lifesciences Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Edwards Lifesciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.0077 | |
β | Beta against Dow Jones | -0.11 | |
σ | Overall volatility | 1.41 | |
Ir | Information ratio | -0.06 |
Edwards Lifesciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Edwards Lifesciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Edwards Lifesciences Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Edwards Lifesciences generated a negative expected return over the last 90 days | |
| Edwards Lifesciences is unlikely to experience financial distress in the next 2 years | |
| Over 90.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference |
Edwards Lifesciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Edwards Stock often depends not only on the future outlook of the current and potential Edwards Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Edwards Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 599.3 M | |
| Cash And Short Term Investments | 4 B |
Edwards Lifesciences Fundamentals Growth
Edwards Stock prices reflect investors' perceptions of the future prospects and financial health of Edwards Lifesciences, and Edwards Lifesciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Edwards Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0772 | ||||
| Profit Margin | 0.23 % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 44.82 B | ||||
| Shares Outstanding | 580.3 M | ||||
| Price To Earning | 32.77 X | ||||
| Price To Book | 4.67 X | ||||
| Price To Sales | 7.96 X | ||||
| Revenue | 5.44 B | ||||
| Gross Profit | 4.6 B | ||||
| EBITDA | 1.72 B | ||||
| Net Income | 4.17 B | ||||
| Cash And Equivalents | 3.05 B | ||||
| Cash Per Share | 2.81 X | ||||
| Total Debt | 700 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 3.83 X | ||||
| Book Value Per Share | 17.57 X | ||||
| Cash Flow From Operations | 542.3 M | ||||
| Earnings Per Share | 2.22 X | ||||
| Market Capitalization | 46.83 B | ||||
| Total Asset | 13.06 B | ||||
| Retained Earnings | 13.17 B | ||||
| Working Capital | 4.78 B | ||||
| Current Asset | 2.05 B | ||||
| Current Liabilities | 476.2 M | ||||
About Edwards Lifesciences Performance
Evaluating Edwards Lifesciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Edwards Lifesciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Edwards Lifesciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 319.45 | 335.42 | |
| Return On Tangible Assets | 0.37 | 0.39 | |
| Return On Capital Employed | 0.11 | 0.14 | |
| Return On Assets | 0.29 | 0.30 | |
| Return On Equity | 0.38 | 0.39 |
Things to note about Edwards Lifesciences Corp performance evaluation
Checking the ongoing alerts about Edwards Lifesciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Edwards Lifesciences Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Edwards Lifesciences generated a negative expected return over the last 90 days | |
| Edwards Lifesciences is unlikely to experience financial distress in the next 2 years | |
| Over 90.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference |
- Analyzing Edwards Lifesciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Edwards Lifesciences' stock is overvalued or undervalued compared to its peers.
- Examining Edwards Lifesciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Edwards Lifesciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Edwards Lifesciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Edwards Lifesciences' stock. These opinions can provide insight into Edwards Lifesciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.